Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | POLA1 | P09884 | 1/20 | 0.70 |
| ▸ | CYP46A1 | Q9Y6A2 | 2/20 | 0.69 |
| ▸ | USP2 | O75604 | 2/20 | 0.65 |
| ▸ | LMNA | P02545 | 1/20 | 0.65 |
| ▸ | ABCB1 | P08183 | 1/20 | 0.65 |
| ▸ | OSBP | P22059 | 1/20 | 0.65 |
| ▸ | RORC | P51449 | 1/20 | 0.65 |
| ▸ | OSBP2 | Q969R2 | 1/20 | 0.65 |
| ▸ | PLA2G2A | P14555 | 1/20 | 0.62 |
| ▸ | NPC1 | O15118 | 1/20 | 0.59 |
| ▸ | NR1H3 | Q13133 | 2/20 | 0.58 |
| ▸ | NPC1L1 | Q9UHC9 | 1/20 | 0.58 |
| ▸ | GBA1 | P04062 | 2/20 | 0.58 |
| ▸ | UGCG | Q16739 | 2/20 | 0.58 |
| ▸ | GBA2 | Q9HCG7 | 2/20 | 0.58 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL190539 | 1.00 | POLA1 (0.70) | POLA1CYP46A1USP2LMNAABCB1 | |
| SCHEMBL161747 | 1.00 | POLA1 (0.70) | POLA1CYP46A1USP2LMNAABCB1 | |
| SCHEMBL767706 | 1.00 | POLA1 (0.70) | POLA1CYP46A1USP2LMNAABCB1 | |
| SCHEMBL162885 | 1.00 | POLA1 (0.70) | POLA1CYP46A1USP2LMNAABCB1 | |
| SCHEMBL22620094 | 1.00 | POLA1 (0.70) | POLA1CYP46A1USP2LMNAABCB1 | |
| SCHEMBL21177689 | 1.00 | POLA1 (0.70) | POLA1CYP46A1USP2LMNAABCB1 | |
| SCHEMBL412985 | 1.00 | POLA1 (0.70) | POLA1CYP46A1USP2LMNAABCB1 | |
| SCHEMBL140321 | 1.00 | POLA1 (0.70) | POLA1CYP46A1USP2LMNAABCB1 | |
| SCHEMBL18006649 | 1.00 | POLA1 (0.70) | POLA1CYP46A1USP2LMNAABCB1 | |
| SCHEMBL9436821 | 1.00 | POLA1 (0.70) | POLA1CYP46A1USP2LMNAABCB1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1236 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4747627-A1 | METHODS AND SYSTEMS FOR PREDICTIVE CLASSIFICATION BY MASS SPECTROMETRY AND TRAINED LARGE SPECTRAL MODELS | Matterworks Inc (US) | 2026-05-27 | — | — | EP | claimed |
| WO-2026090590-A1 | NANOPARTICLE FORMULATIONS FOR THE DELIVERY OF DNA TO ADIPOSE TISSUE | Remedium Bio, Inc. (US) | 2026-04-30 | — | — | WO | claimed |
| US-12447160-B2 | Topical treatment of wounds with statins and cholesterol for scar reduction | NORTHWESTERN UNIVERSITY (US) | 2025-10-21 | — | — | US | claimed |
| US-20250319079-A1 | COMPOSITION CONTAINING ANTITUMOR DRUG, AND PREPARATION METHOD THEREOF AND USE THEREOF | KUNSHAN XINYUNDA BIOTECH CO., LTD. (CN) | 2025-10-16 | — | — | US | claimed |
| US-12370187-B2 | Composition containing antitumor drug, and preparation method thereof and use thereof | KUNSHAN XINYUNDA BIOTECH CO., LTD. (CN) | 2025-07-29 | — | — | US | claimed |
| WO-2025151073-A1 | COMPOSITION AND NANOPARTICLE SUITABLE FOR USE IN THE DELIVERY OF A THERAPEUTIC AGENT | AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (SG) | 2025-07-17 | — | — | WO | claimed |
| CN-119959397-A | Method for simultaneously detecting multiple cholesteric liquid crystal monomers in environmental medium | 暨南大学 | 2025-05-09 | — | — | CN | claimed |
| WO-2025019764-A1 | METHODS AND SYSTEMS FOR PREDICTIVE CLASSIFICATION BY MASS SPECTROMETRY AND TRAINED LARGE SPECTRAL MODELS | MATTERWORKS INC (US) | 2025-01-23 | — | — | WO | claimed |
| US-20240369580-A1 | METHODS FOR EVALUATING AND IMPROVING COGNITIVE FUNCTION | THE FLOREY INSTITUTE OF NEUROSCIENCE AND MENTAL HEALTH (AU) | 2024-11-07 | — | — | US | claimed |
| US-20240342133-A1 | TOPICAL STATIN FORMULATION FOR TREATMENT OF LICHEN SCLEROSUS AND PSORIASIS | TBT PHARMA INC (US) | 2024-10-17 | — | — | US | claimed |
| EP-0607118-A4 | A PHOSPHOLIPID DELIVERY SYSTEM. | COZZARELLI FRANK JR (US) | 1993-03-17 | — | — | EP | claimed |
| US-5192507-A | Immobilization and detection of narcotics | ARTHUR D. LITTLE, INC. (US) | 1993-03-09 | — | — | US | claimed |
| US-5174988-A | PHOSPHOLIPID DELIVERY SYSTEM | SCIENTIFIC DEVELOPMENT & RESEARCH, INC. (US) | 1992-12-29 | — | — | US | claimed |
| US-5001048-A | Electrical biosensor containing a biological receptor immobilized and stabilized in a protein film | AURTHUR D. LITTLE, INC. (US) | 1991-03-19 | — | — | US | claimed |
| WO-1991001765-A1 | A PHOSPHOLIPID DELIVERY SYSTEM | COZZARELLI, FRANK, JR. (US) | 1991-02-21 | — | — | WO | claimed |
| EP-0367788-A1 | RECEPTOR-BASED BIOSENSORS | ARTHUR D. LITTLE, INC. (US) | 1990-05-16 | — | — | EP | claimed |
| WO-1988009808-A2 | RECEPTOR-BASED BIOSENSORS | ARTHUR D. LITTLE, INC. (US) | 1988-12-15 | — | — | WO | claimed |
| US-4687744-A | INCUBATING ZOOSPORES WITH STEROL AND FATTY ACID MEDIUM | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 1987-08-18 | — | — | US | claimed |
| EP-0227299-A2 | Polymer/liquid crystal composite semipermeable membranes and process for the use thereof | THE STANDARD OIL COMPANY (US) | 1987-07-01 | — | — | EP | claimed |
| US-3956169-A | DISPLAY DEVICE | HITACHI, LTD. (JA) | 1976-05-11 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12370187-B2 | Composition containing antitumor drug, and preparation method thereof and use thereof | MTTP, CETP, ALB | POLA1 3480/4885CYP46A1 4/4885USP2 2804/4885 |
| US-20240369580-A1 | METHODS FOR EVALUATING AND IMPROVING COGNITIVE FUNCTION | CETP, LIPA, CES1 | POLA1 4223/4885CYP46A1 5/4885USP2 1559/4885 |
| US-20250319079-A1 | COMPOSITION CONTAINING ANTITUMOR DRUG, AND PREPARATION METHOD THEREOF AND USE THEREOF | MTTP, CETP, ALB | POLA1 3480/4885CYP46A1 4/4885USP2 2804/4885 |
| US-20240342133-A1 | TOPICAL STATIN FORMULATION FOR TREATMENT OF LICHEN SCLEROSUS AND PSORIASIS | LSS, LIPA, HMGCR | POLA1 1715/4885CYP46A1 21/4885USP2 3145/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.